4-[(6-bromohexyl)oxy]-4'-fluorobenzophenone | 134994-52-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-[(6-bromohexyl)oxy]-4'-fluorobenzophenone
• 英文别名: [4-[(6-Bromohexyl)oxy]phenyl](4-fluorophenyl)methanone；[4-(6-bromohexoxy)phenyl]-(4-fluorophenyl)methanone
• CAS: 134994-52-8
• 化学式: C₁₉H₂₀BrFO₂
• 分子量: 379.269
• InChiKey: OEKGFTVCLGZDSL-UHFFFAOYSA-N

物化性质

• 沸点：
  480.1±40.0 °C(Predicted)
• 密度：
  1.301±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  23
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-甲基烯丙基胺 、 4-[(6-bromohexyl)oxy]-4'-fluorobenzophenone 以 N,N-二甲基乙酰胺 为溶剂， 反应 72.0h， 生成 [4-[6-(allylmethylamino)hexyloxy]phenyl](4-fluorophenyl)methanone hydrobromide
  参考文献：
  名称：

  Synthesis and Structure−Activity Studies of Novel Orally Active Non-Terpenoic 2,3-Oxidosqualene Cyclase Inhibitors

  摘要：

  New orally active non-terpenoic inhibitors of human 2,3-oxidosqualene cyclase (hOSC) are reported. The starting point for the optimization process was a set of compounds derived from a fungicide project, which in addition to showing high affinity for OSC from Candida albicans showed also high affinity for human OSC. Common structural elements of these inhibitors are an amine residue and an electrophilic carbonyl C atom embedded in a benzophenone system, which are at a distance of about 10.7 Angstrom. Considering that the keto moiety is in a potentially labile position, modifications of the substitution pattern at the benzophenone as well as annelated heteroaryl systems were explored. Our approach combined testing of the compounds first for increased binding affinity and for increased stability in vitro. Most promising compounds were then evaluated for their efficacy in lowering plasma total cholesterol (TC) and plasma low-density lipoprotein cholesterol (LDL-C) in hyperlipidemic hamsters. In this respect, the most promising compounds are the benzophenone derivative 1.fumarate and the benzo[d]-isothiazol 24.fumarate, which lowered TC by 40% and 33%, respectively.

  DOI：

  10.1021/jm021120f
• 作为产物：
  描述：

  4-氟-4'-甲氧基二苯甲酮 在 sodium hydroxide 、 四丁基溴化铵 、 氢溴酸 、 溶剂黄146 作用下， 以 二氯甲烷 为溶剂， 反应 41.0h， 生成 4-[(6-bromohexyl)oxy]-4'-fluorobenzophenone
  参考文献：
  名称：

  Synthesis and Structure−Activity Studies of Novel Orally Active Non-Terpenoic 2,3-Oxidosqualene Cyclase Inhibitors

  摘要：

  New orally active non-terpenoic inhibitors of human 2,3-oxidosqualene cyclase (hOSC) are reported. The starting point for the optimization process was a set of compounds derived from a fungicide project, which in addition to showing high affinity for OSC from Candida albicans showed also high affinity for human OSC. Common structural elements of these inhibitors are an amine residue and an electrophilic carbonyl C atom embedded in a benzophenone system, which are at a distance of about 10.7 Angstrom. Considering that the keto moiety is in a potentially labile position, modifications of the substitution pattern at the benzophenone as well as annelated heteroaryl systems were explored. Our approach combined testing of the compounds first for increased binding affinity and for increased stability in vitro. Most promising compounds were then evaluated for their efficacy in lowering plasma total cholesterol (TC) and plasma low-density lipoprotein cholesterol (LDL-C) in hyperlipidemic hamsters. In this respect, the most promising compounds are the benzophenone derivative 1.fumarate and the benzo[d]-isothiazol 24.fumarate, which lowered TC by 40% and 33%, respectively.

  DOI：

  10.1021/jm021120f

文献信息

• Substituted aminoalkoxybenzene anti-fungicidal compositions and use
  申请人：Hoffmann-La Roche Inc.

  公开号：US05214046A1

  公开（公告）日：1993-05-25

  The compound of the formula ##STR1## wherein each of R.sup.1 and R.sup.2 individually is hydrogen, lower alkyl or lower alkenyl or together signify straight-chain alkylene with 2 to 4 carbon atoms, R.sup.3 is hydrogen, halogen or lower alkyl, Q is alkylene with 4 to 11 carbon atoms and at least 4 carbon atoms between the two free valencies or alkenylene with 4 to 11 carbon atoms and at least 4 carbon atoms between the two free valencies and each of Y and Y' individually is a direct bond or the group --CH.sub.2 --, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH-- or --C.tbd.C--, the group R.sup.1 R.sup.2 N--Q--O-- is attached to the 3- or 4 -position of ring A and the symbol R designates that the ring to which it is attached is unsubstituted or is substituted with at least one substitutent selected from the group consisting of halogen, trifluoromethyl, cyano, nitro, lower alkyl and lower alkoxy, and their pharmaceutically acceptable acid addition salts can be used for the control or prevention of fungal infections, especially of topical or systemic infections which are caused by pathogenic fungi, and for the manufacture of antifungally-active medicaments. The compounds of formula I have not only a pronounced antifungal activity, but they also exhibit synergistic effects in combination with other known antifungally-active substances which inhibit sterol biosynthesis such as ketoconazole and terbinafine.

  该化合物的化学式为##STR1##，其中R.sup.1和R.sup.2分别为氢、低碳烷基或低碳烯基，或者一起表示具有2至4个碳原子的直链烷基；R.sup.3为氢、卤素或低碳烷基；Q为具有4至11个碳原子且两个自由价键之间至少有4个碳原子的烷基，或者具有4至11个碳原子且两个自由价键之间至少有4个碳原子的烯基；Y和Y'中的每一个都是直接键或基团--CH.sub.2 --、--CH.sub.2 CH.sub.2 --、--CH.dbd.CH--或--C.tbd.C--；基团R.sup.1 R.sup.2 N--Q--O--连接到环A的3-或4-位置，符号R表示其连接的环未被取代或者被取代至少一个取代基，该取代基可从卤素、三氟甲基、氰基、硝基、低碳烷基和低碳烷氧基组成的群体中选择，且它们的药学上可接受的酸盐可用于控制或预防由致病真菌引起的真菌感染，特别是局部或全身感染，用于制造具有抗真菌活性的药物。化合物I的化学式不仅具有明显的抗真菌活性，而且与其他已知抑制固醇生物合成的抗真菌活性物质（如酮康唑和特比萘芬）结合时还表现出协同效应。
• Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer’s Disease
  作者：Justyna Godyń、Paula Zaręba、Dorota Stary、Maria Kaleta、Kamil J. Kuder、Gniewomir Latacz、Szczepan Mogilski、David Reiner-Link、Annika Frank、Agata Doroz-Płonka、Agnieszka Olejarz-Maciej、Sylwia Sudoł-Tałaj、Tobias Nolte、Jadwiga Handzlik、Holger Stark、Anna Więckowska、Barbara Malawska、Katarzyna Kieć-Kononowicz、Dorota Łażewska、Marek Bajda

  DOI：10.3390/molecules28010238

  日期：——

  histamine H3 receptor and additional cholinesterase inhibitory potency represent a promising strategy for research into the effective treatment of Alzheimer's disease. In this study, a novel series of benzophenone derivatives was designed and synthesized. Among these derivatives, we identified compound 6 with a high affinity for H3R (Ki = 8 nM) and significant inhibitory activity toward BuChE (IC50 = 172

  显示出对组胺 H3 受体的亲和力和额外的胆碱酯酶抑制效力的多靶点定向配体代表了研究有效治疗阿尔茨海默氏病的有前途的策略。在本研究中，设计并合成了一系列新型二苯甲酮衍生物。在这些衍生物中，我们发现化合物 6 对 H3R 具有高亲和力 (Ki = 8 nM)，并且对 BuChE 具有显着抑制活性（eqBuChE 和 hBuChE 的 IC50 分别为 172 nM 和 1.16 µM）。进一步的体外研究表明，化合物 6（4-氟苯基）（4-（（5-（哌啶-1-基）戊基）氧基）苯基）甲酮）在小鼠肝微粒体中表现出适度的代谢稳定性，良好的渗透性和渗透系数6.3 × 10-6 cm/s 的值 (Pe)，其安全性在 HepG2 细胞系的肝毒性方面得到证实。因此，我们研究了化合物 6 在被动回避试验和福尔马林试验中的体内活性。虽然化合物 6 对记忆和学习没有显示出统计学上的显着影响，但它在急性 (ED50 =
• Substituierte Aminoalkoxybenzolderivate
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP0410359A1

  公开（公告）日：1991-01-30

  Die Verbindungen der Formel worin R¹ und R² je Wasserstoff, niederes Alkyl oder niederes Alkenyl oder zusammen geradkettiges Alkylen mit 2 bis 4 Kohlenstoffatomen, R³ Wasserstoff, Halogen oder niederes Alkyl, Q Alkylen oder Alkenylen mit 4 bis 11 Kohlenstoffatomen und mindestens 4 Kohlenstoffatomen zwischen den zwei freien Valenzen und Y und Y′ je eine direkte Bindung oder die Gruppe -CH₂-, -CH₂CH₂-, -CH=CH- oder -C≡C- bedeuten, die Gruppe R¹R²N-Q-O- an die 3- oder 4-Stellung des mit A bezeichneten Ringes gebunden ist und das Symbol R bedeutet, dass der Ring unsubstituiert oder durch Halogen, Trifluormethyl, Cyano, Nitro, niederes Alkyl und/oder niederes Alkoxy einfach oder mehrfach substi­tuiert ist, und ihre pharmazeutisch annehmbaren Säureadditionssalze können zur Bekämpfung oder Verhütung von fungalen Infektionen, insbesondere von topischen oder systemischen Infektionen, welche durch pathogene Pilze verursacht werden, und zur Herstellung von antifungal wirksamen Mitteln verwendet werden. Die Verbindungen der Formel I besitzen nicht nur eine ausgeprägte antifungale Wirkung, sondern sie zeigen auch synergistische Effekte in Kombination mit anderen, bekannten, antifungal wirksamen Substanzen, welche die Sterol-Biosynthese hemmen, wie Ketoconazol und Terbinafin.

  式中的化合物 其中 R¹ 和 R² 分别为氢、低级烷基或低级烯基或具有 2 至 4 个碳原子的直链亚烷基，R³ 为氢、卤素或低级烷基，Q 为具有 4 至 11 个碳原子且在两个游离价之间至少有 4 个碳原子的亚烷基或烯基，Y 和 Y′ 分别为直接键或基团 -CH₂-、-CH₂CH₂-、-CH=CH- 或 -C≡C-，基团 R¹R²N-Q-O- 与 A 指定的环的 3 位或 4 位键合，符号 R 表示环未被取代或被卤素、三氟甲基、氰基、硝基、低级烷基和/或低级烷氧基单取代或多取代、 及其药学上可接受的酸加成盐可用于控制或预防真菌感染，特别是由病原真菌引起的局部或全身感染，以及制备抗真菌制剂。式 I 的化合物不仅具有明显的抗真菌效果，而且与其他已知的抑制甾醇生物合成的抗真菌活性物质（如酮康唑和特比萘芬）联合使用时还会产生协同效应。
• US5106878A
  申请人：——

  公开号：US5106878A

  公开（公告）日：1992-04-21
• US5214046A
  申请人：——

  公开号：US5214046A

  公开（公告）日：1993-05-25